Literature DB >> 12637767

Cell cycle control mechanisms in B-1 and B-2 lymphoid subsets.

Michael J Piatelli1, Debra Tanguay, Thomas L Rothstein, Thomas C Chiles.   

Abstract

An effective humoral response requires that a given B lymphocyte population express a repertoire of receptors capable of recognizing a distinct array of antigens, while at the same time disregarding self-antigens. Mature B cells interacting with antigen via their B cell antigen receptors (BCRs) enter G(1) phase of the cell cycle and, depending on the strength of the signal, can commit to S phase entry. Input from co-receptors, which may function to either enhance or inhibit BCR signals, also influence the decision to proliferate. We review herein recent advances in the biochemistry of G(1)-cyclin holoenzymes that function to integrate BCR-coupled signaling pathways to the phosphorylation (and inactivation) of the retinoblastoma gene product (pRb) in splenic B lymphocytes (B-2 cells). We also highlight differences in the control of G(1)-to-S phase progression between B-2 cells and peritoneal CD5+ B cells (B-1 cells).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12637767     DOI: 10.1385/IR:27:1:31

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  132 in total

Review 1.  Cell-cycle inhibitors: three families united by a common cause.

Authors:  A Vidal; A Koff
Journal:  Gene       Date:  2000-04-18       Impact factor: 3.688

2.  Decreased surface IgM receptor-mediated activation of phospholipase C gamma 2 in B-1 lymphocytes.

Authors:  D L Morris; T L Rothstein
Journal:  Int Immunol       Date:  1994-07       Impact factor: 4.823

Review 3.  The regulation of E2F by pRB-family proteins.

Authors:  N Dyson
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

4.  Pillars article: Identification of a T cell-derived B cell growth factor distinct from interleukin 2. J. Exp. Med. 1982. 155: 914-923.

Authors:  Maureen Howard; John Farrar; Mary Hilfiker; Barbara Johnson; Kiyoshi Takatsu; Toshiyuki Hamaoka; William E Paul
Journal:  J Immunol       Date:  2013-02-01       Impact factor: 5.422

5.  Peritoneal B cells respond to phorbol esters in the absence of co-mitogen.

Authors:  T L Rothstein; D L Kolber
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

6.  Phorbol ester responsiveness of murine Ly-1-lineage B cells from normal and viable motheaten mutant mice.

Authors:  D L Kolber; L D Shultz; T L Rothstein
Journal:  Eur J Immunol       Date:  1991-03       Impact factor: 5.532

7.  Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle.

Authors:  A Koff; A Giordano; D Desai; K Yamashita; J W Harper; S Elledge; T Nishimoto; D O Morgan; B R Franza; J M Roberts
Journal:  Science       Date:  1992-09-18       Impact factor: 47.728

8.  Lymphoma models for B-cell activation and tolerance: anti-immunoglobulin M treatment induces growth arrest by preventing the formation of an active kinase complex which phosphorylates retinoblastoma gene product in G1.

Authors:  L F Joseph; S Ezhevsky; D W Scott
Journal:  Cell Growth Differ       Date:  1995-01

9.  Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation.

Authors:  J Bartkova; J Lukas; M Strauss; J Bartek
Journal:  Oncogene       Date:  1998-08-27       Impact factor: 9.867

10.  Frequency of B lymphocytes responsive to anti-immunoglobulin.

Authors:  A L Defranco; E S Raveche; R Asofsky; W E Paul
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

View more
  11 in total

1.  Leptin signaling maintains B-cell homeostasis via induction of Bcl-2 and Cyclin D1.

Authors:  Queenie Lai Kwan Lam; Shengjun Wang; Otis King Hung Ko; Paul W Kincade; Liwei Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-19       Impact factor: 11.205

Review 2.  Contribution of B-1a cells to systemic lupus erythematosus in the NZM2410 mouse model.

Authors:  Zhiwei Xu; Laurence Morel
Journal:  Ann N Y Acad Sci       Date:  2015-02-26       Impact factor: 5.691

3.  Epigenetics in systemic lupus erythematosus: leading the way for specific therapeutic agents.

Authors:  Matlock A Jeffries; Amr H Sawalha
Journal:  Int J Clin Rheumtol       Date:  2011-08

4.  Transcriptional landscape of the human cell cycle.

Authors:  Yin Liu; Sujun Chen; Su Wang; Fraser Soares; Martin Fischer; Feilong Meng; Zhou Du; Charles Lin; Clifford Meyer; James A DeCaprio; Myles Brown; X Shirley Liu; Housheng Hansen He
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-13       Impact factor: 11.205

5.  Cyclin-dependent kinase inhibitor Cdkn2c deficiency promotes B1a cell expansion and autoimmunity in a mouse model of lupus.

Authors:  Hari-Hara S K Potula; Zhiwei Xu; Leilani Zeumer; Allison Sang; Byron P Croker; Laurence Morel
Journal:  J Immunol       Date:  2012-08-15       Impact factor: 5.422

6.  Single round of antigen receptor signaling programs naive B cells to receive T cell help.

Authors:  Bazarragchaa Damdinsuren; Yongqing Zhang; Ashraf Khalil; William H Wood; Kevin G Becker; Mark J Shlomchik; Ranjan Sen
Journal:  Immunity       Date:  2010-03-11       Impact factor: 31.745

7.  Cyclin-dependent kinase inhibitor Cdkn2c regulates B cell homeostasis and function in the NZM2410-derived murine lupus susceptibility locus Sle2c1.

Authors:  Zhiwei Xu; Hari-Hara S K Potula; Anusha Vallurupalli; Daniel Perry; Henry Baker; Byron P Croker; Igor Dozmorov; Laurence Morel
Journal:  J Immunol       Date:  2011-05-04       Impact factor: 5.422

8.  Krüppel-like factor 4 regulates B cell number and activation-induced B cell proliferation.

Authors:  Jettanong Klaewsongkram; Yinhua Yang; Susanne Golech; Jonathan Katz; Klaus H Kaestner; Nan-Ping Weng
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

9.  B cells in murine cervical lymph nodes are conventional B-2 cells.

Authors:  Seung Geun Yeo; Joong Saeng Cho; Dong Choon Park
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

10.  Roles for BLyS family members in meeting the distinct homeostatic demands of innate and adaptive B cells.

Authors:  Vishal J Sindhava; Jean L Scholz; Michael P Cancro
Journal:  Front Immunol       Date:  2013-02-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.